BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/15/2024 2:49:02 AM | Browse: 106 | Download: 298
 |
Received |
|
2023-12-18 03:40 |
|
Peer-Review Started |
|
2023-12-18 03:40 |
|
First Decision by Editorial Office Director |
|
2024-01-04 09:05 |
|
Return for Revision |
|
2024-01-04 12:34 |
|
Revised |
|
2024-01-19 14:43 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-04-03 01:38 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-04-03 02:36 |
|
Articles in Press |
|
2024-04-03 02:36 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-05-14 12:36 |
|
Publish the Manuscript Online |
|
2024-06-15 02:49 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Predicting the prognosis of hepatic arterial infusion chemotherapy in hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qi-Feng Wang, Zong-Wei Li, Hai-Feng Zhou, Kun-Zhong Zhu, Ya-Jing Wang, Ya-Qin Wang and Yue-Wei Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Research Fund of Beijing Tsinghua Changgung Hospital |
12021C11016 |
|
| Corresponding Author |
Ya-Qin Wang, Doctor, Doctor, Doctor, Hepatobiliary Pancreatic Center Department, Beijing Tsinghua Changgung Hospital Affiliated to Tsinghua University, 168 Litang Road, Beijing, Beijing 102218, China. wyqa03622@btch.edu.cn |
| Key Words |
Hepatocellular carcinoma; Hepatic artery infusion chemotherapy; Prediction; Prognosis; Imaging; Biomarkers; Genomics |
| Core Tip |
Hepatic artery infusion chemotherapy (HAIC) has good clinical efficacy and high safety, and it has become one of the main treatment options for patients with intermediate to advanced hepatocellular carcinoma (HCC). Through predicting the prognosis of HAIC, appropriate patients can be screened for HAIC, and the overall efficacy of HAIC in HCC patients can improve. This review summarized the strategies currently used to predict the efficacy of HAIC in middle and advanced HCC, analyzed each marker's ability to predict HAIC efficacy, and provided a reference for the clinical selection of an appropriate HAIC prediction modality. |
| Publish Date |
2024-06-15 02:49 |
| Citation |
Wang QF, Li ZW, Zhou HF, Zhu KZ, Wang YJ, Wang YQ, Zhang YW. Predicting the prognosis of hepatic arterial infusion chemotherapy in hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(6): 2380-2393 |
| URL |
https://www.wjgnet.com/1948-5204/full/v16/i6/2380.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v16.i6.2380 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
